UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Les cancers du poumon avec une mutation oncogénique : une prise en charge de plus en plus spécifique

Oncologie (Paris, France), 2016-06, Vol.18 (6), p.371-375

Auliac, J.-B.

2016

Volltextzugriff (PDF)

Artificial intelligence to finally enable precision medicine for the management of resected non-small-cell lung cancer

Annals of oncology, 2023-07, Vol.34 (7), p.565-566

2023

Volltextzugriff (PDF)

Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients

Respiratory medicine and research, 2020-03, Vol.77, p.46-54

2020

Volltextzugriff (PDF)

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

Lung cancer (Amsterdam, Netherlands), 2014-09, Vol.85 (3), p.415-419

2014

Volltextzugriff (PDF)

Neutropénie fébrile au cours des cancers pulmonaires

Revue des maladies respiratoires actualités, 2017-09, Vol.9 (2), p.413-419

2017

Volltextzugriff (PDF)

Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14

Current oncology (Toronto), 2018-10, Vol.25 (5), p.e398-402

2018

Volltextzugriff (PDF)

EVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients

Annals of oncology, 2018-10, Vol.29, p.viii532-viii532

2018

Volltextzugriff (PDF)

Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study

Annals of oncology, 2019-04, Vol.30, p.ii48-ii48

2019

Volltextzugriff (PDF)

PD-L1 expression pattern in large cell neuroendocrine carcinoma of the lung

Annals of oncology, 2018-10, Vol.29, p.viii48-viii49

2018

Volltextzugriff (PDF)

Follow-up of Bronchial Precancerous Lesions and Carcinoma in Situ Using Fluorescence Endoscopy

American journal of respiratory and critical care medicine, 2001-11, Vol.164 (9), p.1688-1693

2001

Volltextzugriff (PDF)

Causes méconnues de toux chronique

Revue des maladies respiratoires, 2002, Vol.19 (2), p.207-216

2002

Volltextzugriff (PDF)

Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study

Targeted oncology, 2016-04, Vol.11 (2), p.167-174

2016

Volltextzugriff (PDF)

Occupational and nonoccupational factors associated with high grade bronchial pre-invasive lesions

The European respiratory journal, 2003-02, Vol.21 (2), p.332-341

2003

Volltextzugriff (PDF)

Étude en vie réelle de l’usage du pémétrexed en France

Revue des maladies respiratoires, 2017-01, Vol.34, p.A91-A92

2017

Volltextzugriff (PDF)

Caractéristiques cliniques et séquences thérapeutiques des patients atteints de cancer bronchique non à petites cellules (CBNPC) métastatique avec mutation KRAS G12C traités par sotorasib dans l’ATUc

Revue des maladies respiratoires actualités, 2024-01, Vol.16 (1), p.265-266

2024

Volltextzugriff (PDF)

A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)

Annals of oncology, 2022-09, Vol.33 (7), p.S1028-S1029

2022

Volltextzugriff (PDF)

Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Annals of oncology, 2022-09, Vol.33 (7), p.S987-S987

2022

Volltextzugriff (PDF)

Léiomyosarcome médiastinal

Revue des maladies respiratoires, 1999, Vol.16 (2), p.210-213

1999

Volltextzugriff (PDF)

1494PEffectiveness and safety of nivolumab in the treatment of lung cancer patients in France: Updated survival and subgroup analysis from the real-world EVIDENS study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

116OHealth-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Non small cell lung cancer (NSCLC) patients harboring BRAF mutation: Clinical characteristics and management in real world setting. Cohort BRAF EXPLORE GFPC 02-14

Annals of oncology, 2016-10, Vol.27, p.vi439-vi439

2016

Volltextzugriff (PDF)

1469PEVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

Journal of thoracic oncology, 2011-03, Vol.6 (3), p.576-582

2011

Volltextzugriff (PDF)

P1.04-31 Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S537-S538

2018

Volltextzugriff (PDF)

154PPD-L1 expression pattern in large cell neuroendocrine carcinoma of the lung

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(27)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Male
(20)
Female
(15)
Oncology
(14)
Adult
(12)
Aged
(12)
Middle Aged
(12)
Sciences Biologiques Et Medicales
(12)
Sciences Medicales
(12)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Respiratory System
(10)
Chemotherapy
(9)
Lung Neoplasms - Pathology
(9)
Life Sciences
(8)
Lung Neoplasms - Drug Therapy
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Cancer
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Les cancers du poumon avec une mutation oncogénique : une prise en charge de plus en plus spécifique

Artificial intelligence to finally enable precision medicine for the management of resected non-small-cell lung cancer

Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

Neutropénie fébrile au cours des cancers pulmonaires

Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14

EVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients

Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study

PD-L1 expression pattern in large cell neuroendocrine carcinoma of the lung

Follow-up of Bronchial Precancerous Lesions and Carcinoma in Situ Using Fluorescence Endoscopy

Causes méconnues de toux chronique

Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study

Occupational and nonoccupational factors associated with high grade bronchial pre-invasive lesions

Étude en vie réelle de l’usage du pémétrexed en France

Caractéristiques cliniques et séquences thérapeutiques des patients atteints de cancer bronchique non à petites cellules (CBNPC) métastatique avec mutation KRAS G12C traités par sotorasib dans l’ATUc

A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)

Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Léiomyosarcome médiastinal

1494PEffectiveness and safety of nivolumab in the treatment of lung cancer patients in France: Updated survival and subgroup analysis from the real-world EVIDENS study

116OHealth-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study

Non small cell lung cancer (NSCLC) patients harboring BRAF mutation: Clinical characteristics and management in real world setting. Cohort BRAF EXPLORE GFPC 02-14

1469PEVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients

Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

P1.04-31 Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study

154PPD-L1 expression pattern in large cell neuroendocrine carcinoma of the lung

Suchergebnisse filtern